{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:32:42Z","timestamp":1790919162628,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.nbd.2006.02.011","type":"journal-article","created":{"date-parts":[[2006,5,13]],"date-time":"2006-05-13T14:24:27Z","timestamp":1147530267000},"page":"190-197","source":"Crossref","is-referenced-by-count":148,"title":["Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice"],"prefix":"10.1016","volume":"23","author":[{"given":"Paolo","family":"Guidetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian P.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona K.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair R.","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcy E.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Slow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schwarcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2006.02.011_bib1","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","article-title":"Huntingtin aggregation and toxicity in Huntington's disease","volume":"361","author":"Bates","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2006.02.011_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2006.02.011_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1385\/MN:27:3:325","article-title":"Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria","volume":"27","author":"Brown","year":"2003","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2006.02.011_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/exnr.1994.1004","article-title":"PET- and MRI-based assessment of glucose utilization, dopamine receptor binding, and hemodynamic changes after lesions to the caudate\u2013putamen in primates","volume":"125","author":"Brownell","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2006.02.011_bib5","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.02.011_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","article-title":"Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea","volume":"263","author":"Coyle","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2006.02.011_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00004647-199907000-00007","article-title":"Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2\u00a0yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia","volume":"19","author":"Cozzi","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2006.02.011_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0306-4522(88)90156-X","article-title":"Sparing of cholinergic neurons following quinolinic acid lesions of the rat striatum","volume":"26","author":"Davies","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2006.02.011_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-8993(89)90216-3","article-title":"Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line","volume":"495","author":"Eastman","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2006.02.011_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0006-8993(92)90883-B","article-title":"Uptake of 3-hydroxykynurenine measured in rat brain slices and in a neuronal cell line","volume":"584","author":"Eastman","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2006.02.011_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jnr.10508","article-title":"Involvement of microglia\u2013neuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin","volume":"71","author":"Eskes","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2006.02.011_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3940(84)90050-8","article-title":"Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid","volume":"48","author":"Foster","year":"1984","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2006.02.011_bib13","doi-asserted-by":"crossref","first-page":"50514","DOI":"10.1074\/jbc.M309348200","article-title":"Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-d-aspartate receptor activation in Huntington's disease knock-in striatal cells","volume":"278","author":"Gines","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2006.02.011_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1542","article-title":"A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease","volume":"37","author":"Giorgini","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2006.02.011_bib15","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1021\/bi992997s","article-title":"3-hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction","volume":"39","author":"Goldstein","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2006.02.011_bib16","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","article-title":"3-hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum","volume":"11","author":"Guidetti","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2006.02.011_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0304-3940(00)00956-3","article-title":"Early kynurenergic impairment in Huntington's disease and in a transgenic animal model","volume":"283","author":"Guidetti","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2006.02.011_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2006.02.011_bib19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2006.02.011_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0896-6273(03)00594-4","article-title":"Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila","volume":"40","author":"Gunawardena","year":"2003","journal-title":"Neuron"},{"issue":"Pt. 5","key":"10.1016\/j.nbd.2006.02.011_bib21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","article-title":"Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease","volume":"115","author":"Heyes","year":"1992","journal-title":"Brain"},{"issue":"Pt. 2","key":"10.1016\/j.nbd.2006.02.011_bib22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj3200595","article-title":"Human microglia convert l-tryptophan into the neurotoxin quinolinic acid","volume":"320","author":"Heyes","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2006.02.011_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse","volume":"61","author":"Hockly","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2006.02.011_bib24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2006.02.011_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002030-199804000-00003","article-title":"Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex","volume":"12","author":"Kerr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.nbd.2006.02.011_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00702-002-0770-z","article-title":"Kynurenate production by cultured human astrocytes","volume":"110","author":"Kiss","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2006.02.011_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease","volume":"58","author":"Levine","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2006.02.011_bib28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2006.02.011_bib29","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2006.02.011_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1566-2772(03)00059-8","article-title":"Mechanisms of transcriptional dysregulation in Huntington's disease","volume":"3","author":"Luthi-Carter","year":"2003","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.nbd.2006.02.011_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2006.02.011_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/NMM:4:1-2:7","article-title":"Huntington's disease","volume":"4","author":"MacDonald","year":"2003","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.nbd.2006.02.011_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","article-title":"Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids","volume":"263","author":"McGeer","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2006.02.011_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1254\/jjp.71.183","article-title":"3-Hydroxykynurenine toxicity on the rat striatum in vivo","volume":"71","author":"Nakagami","year":"1996","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.nbd.2006.02.011_bib35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/ac00101a012","article-title":"Pentafluorobenzylation method for quantification of acidic tryptophan metabolites using electron capture negative ion mass spectrometry","volume":"67","author":"Naritsin","year":"1995","journal-title":"Anal. Chem."},{"key":"10.1016\/j.nbd.2006.02.011_bib36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2006.02.011_bib37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2006.02.011_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(92)90749-W","article-title":"Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease","volume":"144","author":"Pearson","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2006.02.011_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/exnr.2002.7885","article-title":"Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease","volume":"175","author":"Petersen","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2006.02.011_bib40","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2006.02.011_bib41","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1021\/jm970467t","article-title":"Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase","volume":"40","author":"R\u00f6ver","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2006.02.011_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2006.02.011_bib43","series-title":"Ionotropic Glutamate Receptors as Therapeutic Targets","first-page":"587","article-title":"Huntington's disease","author":"Schwarcz","year":"2002"},{"key":"10.1016\/j.nbd.2006.02.011_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.034439","article-title":"Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities","volume":"303","author":"Schwarcz","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2006.02.011_bib45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.nbd.2006.02.011_bib46","series-title":"Parkinsonism and Aging","first-page":"97","article-title":"Kynurenines, glia, and the pathogenesis of neurodegenerative disorders","author":"Schwarcz","year":"1989"},{"key":"10.1016\/j.nbd.2006.02.011_bib47","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism","volume":"14","author":"Seong","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.02.011_bib48","first-page":"212.1","article-title":"Increased ferritin in reactive microglia is present early in striatum of Huntington's disease patients and R6\/2 mice","volume":"31","author":"Simmons","year":"2005","journal-title":"Abstr.-Soc. Neurosci."},{"key":"10.1016\/j.nbd.2006.02.011_bib49","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.02.011_bib50","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions","volume":"102","author":"Slow","year":"2005","journal-title":"Proc. Natl. Acad Sci. U. S. A."},{"key":"10.1016\/j.nbd.2006.02.011_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4522(03)00382-8","article-title":"Neocortical neurons cultured from mice with expanded CAG repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults","volume":"120","author":"Snider","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2006.02.011_bib52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1471-4159.1993.tb05840.x","article-title":"On the production and disposition of quinolinic acid in rat brain and liver slices","volume":"60","author":"Speciale","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2006.02.011_bib53","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington's disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2006.02.011_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(03)00569-5","article-title":"Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport","volume":"40","author":"Szebenyi","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2006.02.011_bib55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2006.02.011_bib56","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1523\/JNEUROSCI.4456-04.2005","article-title":"Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived fas ligand","volume":"25","author":"Taylor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2006.02.011_bib57","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.110078997","article-title":"Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease","volume":"97","author":"Turmaine","year":"2000","journal-title":"Proc. Natl. Acad Sci. U. S. A."},{"key":"10.1016\/j.nbd.2006.02.011_bib58","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","article-title":"Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.02.011_bib59","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2006.02.011_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10715760000300021","article-title":"Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions","volume":"32","author":"Vazquez","year":"2000","journal-title":"Free Radical Res."},{"key":"10.1016\/j.nbd.2006.02.011_bib61","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2006.02.011_bib62","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","article-title":"Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease","volume":"22","author":"Wellington","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2006.02.011_bib63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","article-title":"Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse","volume":"8","author":"Wheeler","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.02.011_bib64","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/hmg\/11.6.633","article-title":"Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice","volume":"11","author":"Wheeler","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2006.02.011_bib65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0304-3940(89)90609-5","article-title":"Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system","volume":"97","author":"Whetsell","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2006.02.011_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","article-title":"Mutant huntingtin enhances excitotoxic cell death","volume":"17","author":"Zeron","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2006.02.011_bib67","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996106000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996106000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T21:08:27Z","timestamp":1586898507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996106000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0969996106000532"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2006.02.011","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}